Antiviral role of nanomaterials: a material scientist's perspective
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ali, Muhammad Aanish | - |
dc.contributor.author | Rehman, Nagina | - |
dc.contributor.author | Park, Tae Joo | - |
dc.contributor.author | Basit, Muhammad Abdul | - |
dc.date.accessioned | 2023-02-21T05:39:52Z | - |
dc.date.available | 2023-02-21T05:39:52Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 2046-2069 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/111562 | - |
dc.description.abstract | The present world continues to face unprecedented challenges caused by the COVID-19 pandemic. Collaboration between researchers of multiple disciplines is the need of the hour. There is a need to develop antiviral agents capable of inhibiting viruses and tailoring existing antiviral drugs for efficient delivery to prevent a surge in deaths caused by viruses globally. Biocompatible systems have been designed using nanotechnological principles which showed appreciable results against a wide range of viruses. Many nanoparticles can act as antiviral therapeutic agents if synthesized by the correct approach. Moreover, nanoparticles can act as carriers of antiviral drugs while overcoming their inherent drawbacks such as low solubility, poor bioavailability, uncontrolled release, and side effects. This review highlights the potential of nanomaterials in antiviral applications by discussing various studies and their results regarding antiviral potential of nanoparticles while also suggesting future directions to researchers. | - |
dc.format.extent | 33 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Royal Society of Chemistry | - |
dc.title | Antiviral role of nanomaterials: a material scientist's perspective | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1039/d2ra06410c | - |
dc.identifier.scopusid | 2-s2.0-85145230057 | - |
dc.identifier.wosid | 000901500200001 | - |
dc.identifier.bibliographicCitation | RSC Advances, v.13, no.1, pp 47 - 79 | - |
dc.citation.title | RSC Advances | - |
dc.citation.volume | 13 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 47 | - |
dc.citation.endPage | 79 | - |
dc.type.docType | Review | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | SOLID LIPID NANOPARTICLES | - |
dc.subject.keywordPlus | INFLUENZA-VIRUS INFECTION | - |
dc.subject.keywordPlus | FUNCTIONALIZED SELENIUM NANOPARTICLES | - |
dc.subject.keywordPlus | SYNTHESIZED SILVER NANOPARTICLES | - |
dc.subject.keywordPlus | LOADED LACTOFERRIN NANOPARTICLES | - |
dc.subject.keywordPlus | CELLULOSE-ACETATE BUTYRATE | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | CHITOSAN NANOPARTICLES | - |
dc.subject.keywordPlus | DRUG-COMBINATION | - |
dc.subject.keywordPlus | DELIVERY-SYSTEM | - |
dc.identifier.url | https://pubs.rsc.org/en/content/articlelanding/2023/RA/D2RA06410C | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.